Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Spacing Lidcombe Program Clinic Visits
for
Stuttering
Location: Montreal
Sponsor: University of Sydney
Sex: All
Age: 3 - 6
Code: NCT00680303
Phase 2, Recruiting
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
for
Osteoporosis
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 55+
Code: NCT00346190
Phase 3, Recruiting
International CRDS Registry
for
Calcium Release Deficiency Syndrome
Location: Quebec, Montreal, Ottawa, Fairfax VA, Durham NC,
Sponsor: Population Health Research Institute
Sex: All
Age: 0+
Code: NCT06508164
Recruiting
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
for
Diabetes Type 1
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT06894784
Phase 3, Recruiting
World Bleeding Disorders Registry
for
Hemophilia A, Hemophilia B, Von Willebrand Diseases
Location: Montreal
Sponsor: World Federation of Hemophilia
Sex: All
Age: 0+
Code: NCT03327779
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 65
Code: NCT05719779
Recruiting
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus
for
Discoid Lupus Erythematosus
Location: Fredericton, Montreal
Sponsor: Innovaderm Research Inc.
Sex: All
Age: 18+
Code: NCT06261021
Phase 2, Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Montreal, Winston-Salem NC, Pittsburgh PA, Charlotte NC,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase 3, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer